"Time sequential high dose of Cytarabine in acute myelocytic leukemia "

"Time sequential high dose of Cytarabine in acute myelocytic leukemia "

Show other versions (1)

Given preliminary evidence of timed, sequential chemotherapy of high dose cytosine arabinoside the current study was initiated to assess the side effects and efficacy of this regimen in patients with newly acute myelocytic leukemia (AML). Nineteen adults who referred to Hematology-Oncology and Bone...

Full description

Bibliographic Details
Main Authors:	Ghavamzadeh A, Jahani M, Alimoghaddam K, Iravani M, Aghadmi N, Tavassoli P
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2003-05-01
Series:	Acta Medica Iranica
Subjects:	Acute myelocytic leukemia Antineoplastic protocols High dose cytarabine
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/1039.pdf&manuscript_id=1039

Similar Items

"Time sequential high dose of Cytarabine in acute myelocytic leukemia "
by: Ghavamzadeh A, et al.
Published: (2003-03-01)

Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience
by: Yasir Bashir, et al.
Published: (2015-01-01)

Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
by: SV Gritsaev, et al.
Published: (2016-01-01)

Different influence of Arac combined with idarubicin and with daunorubicin on malignant molecule expression of acute myelocytic leukemia
by: Abudourexiti Nuerbiya, et al.
Published: (2018-05-01)

TREATMENT WITH LOW-DOSE CYTARABINE IN ELDERLY PATIENTS (AGE 70 YEARS OR OLDER) WITH ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION EXPERIENCE
by: Maël Heiblig, et al.
Published: (2016-01-01)

Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia
by: M.C. Azevedo, et al.
Published: (2015-02-01)

Study of serum antioxidant levels in patients with acute lymphocytic leukemia and chronic myelocytic leukemia before and after vincristine intake
by: Noha altaalib
Published: (2012-12-01)

IGF2BP2 Overexpression Indicates Poor Survival in Patients with Acute Myelocytic Leukemia
by: Xin He, et al.
Published: (2018-12-01)

A case report of hereditary spherocytosis with concomitant chronic myelocytic leukemia
by: Xiaoqiu Wang, et al.
Published: (2016-01-01)

Searching for a signature involving 10 genes to predict the survival of patients with acute myelocytic leukemia through a combined multi-omics analysis
by: Haifeng Zhuang, et al.
Published: (2020-06-01)

Effects of intensive induction and consolidation chemotherapy with idarubicin and high dose cytarabine on minimal residual disease levels in newly diagnosed adult precursor-B acute lymphoblastic leukemia
by: Kenneth F. Bradstock, et al.
Published: (2016-12-01)

Low-Dose Cytarabine versus Best Supportive Care for Patients with Acute Myeloid Leukaemia Unfit for the Standard of Care: Egyptian Centre Experience
by: Amrallah Mohammed, et al.
Published: (2021-07-01)

Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
by: Bożena Katarzyna Budziszewska, et al.
Published: (2021-08-01)

Growth, differentiation, and cell-death-associated expression of the BCL-2 proto-oncogene in human Myeloid Leukaemia cells
by: Becher, Anja
Published: (2016)

Phase I study of ADI‐PEG20 plus low‐dose cytarabine for the treatment of acute myeloid leukemia
by: Hui‐Jen Tsai, et al.
Published: (2021-05-01)

Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels, AKT and ERK1/2 signaling
by: Theresa Lowinus, et al.
Published: (2019-01-01)

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
by: Sook-Kyoung Heo, et al.
Published: (2020-12-01)

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation
by: Harinder Gill, et al.
Published: (2020-05-01)

Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia
by: Stefan Hatzl, et al.
Published: (2020-02-01)

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment
by: Lalit S Raut
Published: (2015-01-01)

The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells
by: Wenxiu Qi, et al.
Published: (2020-12-01)

Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia
by: Axel H. Schönthal, et al.
Published: (2021-07-01)

Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations—Possible Therapeutic Efficacy of Cabozantinib
by: Ya-Chen Ko, et al.
Published: (2019-03-01)

Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia
by: Phu Ngoc Tran, et al.
Published: (2017-05-01)

Role of CD19 and specific KIT‐D816 on risk stratification refinement in t(8;21) acute myeloid leukemia induced with different cytarabine intensities
by: Biao Wang, et al.
Published: (2021-02-01)

Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
by: Chen EC, et al.
Published: (2018-06-01)

Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virus
by: Peng J, et al.
Published: (2018-10-01)

Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
by: Prajwal Boddu, et al.
Published: (2018-09-01)

Cytarabine-Induced Corneal Toxicity: Clinical Features and Relief of Symptoms with Loteprednol Etabonate 0.5% in Two Patients
by: Gökçen Özcan, et al.
Published: (2021-04-01)

Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells
by: Bista, Ranjan, et al.
Published: (2017)

Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice
by: Jason T. Anderson, et al.
Published: (2019-12-01)

Inhibitiory properties of cytoplasmic extract of Lactobacilli isolated from common carp intestine on human chronic myelocytic leukemia K562 cell line: an in vitro study
by: Kabiri F, et al.
Published: (2011-03-01)

Homoharringtonine combined with aclarubicin and cytarabine synergistically induces apoptosis in t(8;21) leukemia cells and triggers caspase‐3‐mediated cleavage of the AML1‐ETO oncoprotein
by: Jiang Cao, et al.
Published: (2016-11-01)

Pharmacokinetics of multivesicular liposomal encapsulated cytarabine when administered subcutaneously in dogs
by: Irene B. Vazquez Fuster, et al.
Published: (2020-07-01)

Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo
by: Yingyu Chen, et al.
Published: (2018-08-01)

CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties
by: Mayer LD, et al.
Published: (2019-05-01)

Therapies for acute myeloid leukemia: vosaroxin
by: Sayar H, et al.
Published: (2017-08-01)

Model based characterization of pharmacokinetic interaction between voriconazole and cytarabine in patients with acute myeloid leukemia
by: Ματθιός, Ανδρέας
Published: (2014)

Assessment of oxidative stress in acute myeloid leukemia
by: Esfahani A, et al.
Published: (2011-02-01)

Chemotherapy-Induced Survivin Regulation in Acute Myeloid Leukemia Cells
by: Petra Otevřelová, et al.
Published: (2021-01-01)